Health in Tech, INC

Health In Tech, Inc. presented an investor deck detailing its AI-powered marketplace for self-funded health plans, highlighting product offerings, market strategy, and financial performance.

Health In Tech announces a CEO transition and discusses Q3 2026 results, highlighting strategic investments in new platforms like HitRix and HITChain, while facing revenue declines and increased operating expenses.

Health In Tech announced its third quarter 2026 financial results, reporting a decrease in revenue and an increase in net loss, alongside a revised full-year revenue outlook.

Health In Tech, Inc. held its 2026 Annual Meeting of Stockholders, with overwhelming support for director elections, share authorization increases, and equity plan amendments.

Health In Tech, Inc. has completed a second closing under its Standby Equity Purchase Agreement, receiving $3 million in gross proceeds through a promissory note.

Health In Tech, Inc. announced the appointment of Sanjay Shrestha as CEO, succeeding founder Tim Johnson who will transition to Executive Chairman, signaling a new phase of growth and strategic expansion.

Health In Tech, Inc. reported a net loss of $7.1 million for Q3 2026, driven by increased credit loss provisions and a decline in revenues, while also securing new financing and announcing leadership transitions.

Health in Tech's Q2 results show a revenue decline and increased expenses, with a new carrier transition impacting operations and a significant convertible financing agreement announced.

Health In Tech reported a 9.4% year-over-year revenue increase to $8.8 million for Q1 2026, driven by its SMR segment, but experienced a widening net loss of $1.6 million.

Health In Tech, Inc. announced significant revenue growth and strategic technology advancements in its Q3 2025 report, despite a temporary pause in its HI Card service.

Health In Tech, Inc. announced significant revenue and profit growth for the first half of 2025, driven by new product demand and increased enrolled employees.

Health In Tech's Q1 2025 shows significant revenue growth driven by new product offerings and expanded adoption of self-funded health plan solutions.

Health In Tech, Inc. announced robust financial performance for fiscal year 2025, driven by significant revenue growth and expanded platform adoption, despite pausing HI Card development.

Health In Tech's 2024 10-K filing highlights a profitable year with a 2% revenue increase, driven by strategic shifts and AI-powered platforms.

Sanjay K Shrestha, Chief Executive Officer and a Director of Health In Tech, Inc., reported multiple transactions in common stock on November 10, 2026.

Linlin Qian, Chief Financial Officer, a Director and 10% owner of Health In Tech, Inc., reported multiple transactions in common stock on November 10, 2026.

Tim Donald Johnson, Executive Chairman, a Director and 10% owner of Health In Tech, Inc., reported multiple transactions in common stock on November 10, 2026.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., sold 1,667 shares of common stock on November 3, 2026 for $0.55 per share.

Sanjay K Shrestha, Chief Executive Officer and a Director of Health In Tech, Inc., reported multiple transactions in common stock on October 20, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 119,728 shares of common stock on October 15, 2026.

Health In Tech, Inc. has issued a proxy statement detailing proposals for its 2026 Annual Meeting, including a significant increase in authorized shares, approval of a standby equity purchase agreement, and amendments to its equity incentive plan.

Health In Tech announced it will host its 2025 Annual Stockholder Meeting virtually on October 3, 2025, for shareholders of record as of August 6, 2025.

Health In Tech, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, an expanded equity incentive plan, and auditor ratification.

Health In Tech, Inc. has filed an amendment to its S-1 registration statement, primarily to update the consent of its independent auditor, MaloneBailey, LLP.

Health In Tech, Inc. has filed an amendment to its S-1 registration statement, detailing a proposed public offering of 2,300,000 shares of Class A Common Stock and a resale of 1,969,585 shares by a selling shareholder.

Health In Tech, Inc. has filed Amendment No. 4 to its Form S-1 registration statement for a proposed IPO of 2,300,000 shares of Class A Common Stock and the potential resale of 1,969,585 shares by a selling shareholder.

Health In Tech, Inc. has filed Amendment No. 3 to its Form S-1 registration statement with the SEC, primarily focusing on exhibits and legal opinions related to the offering of Class A common stock.

Health In Tech, Inc. has filed an amendment to its Form S-1 registration statement, outlining details for a proposed initial public offering of Class A Common Stock and a resale prospectus.

Health In Tech, an insurance technology platform, is seeking to raise capital through an initial public offering (IPO) to fund system enhancements, business expansion, and sales growth, aiming for a Nasdaq listing under the symbol HIT.

Laurence W. Lytton has filed a Schedule 13G, reporting beneficial ownership of 3,317,030 shares, representing 6.2% of Health In Tech, Inc.'s Class A Common Stock.

Zhong Yang Securities Limited has filed an amended Schedule 13G, clarifying that it holds no beneficial ownership in Health In Tech, Inc.'s Class A Common Stock.

LinLin Qian, an individual, has disclosed a beneficial ownership of 24.4% of Health In Tech, Inc.'s Class A Common Stock as of December 31, 2024, comprising a mix of common shares, restricted stock, Class B shares, and stock options.

Tim Johnson, a key individual at Health In Tech, Inc., has disclosed a significant beneficial ownership stake of 60.4% in the company's Class A Common Stock following its recent initial public offering.

Zhong Yang Securities Limited has reported a 9.3% beneficial ownership stake in Health In Tech, Inc.'s Class A Common Stock as of December 31, 2024.